Expansion of myeloid-derived suppressor cells in patients with severe coronavirus disease (COVID-19)
SARS-CoV-2 is associated with a 3.4% mortality rate in patients with severe disease. The pathogenesis of severe cases remains unknown. We performed an in-depth prospective analysis of immune and inflammation markers in two patients with severe COVID-19 disease from presentation to convalescence. Per...
- Autores:
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2020
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- eng
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/12578
- Acceso en línea:
- https://www.nature.com/articles/s41418-020-0572-6
http://hdl.handle.net/20.500.12010/12578
https://doi.org/10.1038/s41418-020-0572-6
- Palabra clave:
- myeloid-derived suppressor cells
severe coronavirus disease
Síndrome respiratorio agudo grave
COVID-19
SARS-CoV-2
Coronavirus
- Rights
- License
- Acceso restringido